Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Kyoto University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Kyoto University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Kyoto University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Kyoto University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Kyoto University, Medical Devices Deals, 2011 to YTD 2017 10
Kyoto University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Kyoto University, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
KinoPharma Raises USD1.3 Million in Financing Round 13
Kyoto University Innovation Capital to Invest in Kyoto drug discovery research institute 14
Stem Cell & Device Laboratory Raises USD1.8 Million in Series A Financing 15
Partnerships 16
Center for iPS Cell Research and Application, Takeda Pharma and RIKEN Enter into Partnership 16
CiRA, Takeda Pharma and Yokohama City University Enter into Research Agreement 17
Oncolys BioPharma Enters into Research Agreement with Kyoto University 18
Center for iPS Cell Research and Application Enters into Agreement with Takeda Pharma 19
Dainippon Sumitomo Pharma Extends Research Agreement with CiRA and Hitachi 20
CiRA Enters into Co-Development Agreement with Takeda Pharma 21
Shin Nippon Biomedical Labs Enters Into Research Agreement With Center For iPS Cells Research And Application 22
NanoCarrier Extends Research Agreement With Kyoto University 23
NanoCarrier Enters Into Research Agreement With Kyoto University 24
CiRA Enters Into Co-Development Agreement With Kyoto University And Dainippon Sumitomo 25
Mitsubishi Tanabe Pharma Enters Into Co-Development Agreement With Kyoto University 26
Takeda Pharma Enters Into Co-Development Agreement With Kyoto University 27
Licensing Agreements 28
FGH Biotech Enters into Licensing Agreement with Kyoto University and Tokyo University of Agriculture and Technology 28
Kyoto Drug Discovery & Development Enters into Licensing Agreement with Kyoto University 29
Sigma Life Science Enters Into Licensing Agreement With Kyoto University 30
iPierian Enters Into Licensing Agreement With Kyoto University 31
Kyoto University And iPS Academia Enter Into Licensing Agreement With iPierian 32
Kyoto University – Key Competitors 33
Kyoto University – Key Employees 34
Kyoto University – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 37
Government and Public Interest 37
Jul 11, 2017: Accessing DNA in the cell’s powerhouse to treat disease 37
Jul 11, 2017: Killing cancer in the heat of the moment 38
Jun 05, 2017: Kyoto University and Astellas Inaugurate “Alliance Station” with Aim of Realizing Advanced Medical Treatments 39
Jun 03, 2016: Unusual combo reduces health risk from atypical antipsychotic 40
Product News 41
May 06, 2016: Researchers Report Progress as They Develop New Approach to Treating Metastatic Melanoma 41
Other Significant Developments 42
Jan 03, 2017: Japan’s foremost medical institute purchases multiple HoloMonitor instruments 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43
Kyoto University, Pharmaceuticals & Healthcare, Key Facts 2
Kyoto University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Kyoto University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Kyoto University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Kyoto University, Deals By Therapy Area, 2011 to YTD 2017 9
Kyoto University, Medical Devices Deals, 2011 to YTD 2017 10
Kyoto University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
KinoPharma Raises USD1.3 Million in Financing Round 13
Kyoto University Innovation Capital to Invest in Kyoto drug discovery research institute 14
Stem Cell & Device Laboratory Raises USD1.8 Million in Series A Financing 15
Center for iPS Cell Research and Application, Takeda Pharma and RIKEN Enter into Partnership 16
CiRA, Takeda Pharma and Yokohama City University Enter into Research Agreement 17
Oncolys BioPharma Enters into Research Agreement with Kyoto University 18
Center for iPS Cell Research and Application Enters into Agreement with Takeda Pharma 19
Dainippon Sumitomo Pharma Extends Research Agreement with CiRA and Hitachi 20
CiRA Enters into Co-Development Agreement with Takeda Pharma 21
Shin Nippon Biomedical Labs Enters Into Research Agreement With Center For iPS Cells Research And Application 22
NanoCarrier Extends Research Agreement With Kyoto University 23
NanoCarrier Enters Into Research Agreement With Kyoto University 24
CiRA Enters Into Co-Development Agreement With Kyoto University And Dainippon Sumitomo 25
Mitsubishi Tanabe Pharma Enters Into Co-Development Agreement With Kyoto University 26
Takeda Pharma Enters Into Co-Development Agreement With Kyoto University 27
FGH Biotech Enters into Licensing Agreement with Kyoto University and Tokyo University of Agriculture and Technology 28
Kyoto Drug Discovery & Development Enters into Licensing Agreement with Kyoto University 29
Sigma Life Science Enters Into Licensing Agreement With Kyoto University 30
iPierian Enters Into Licensing Agreement With Kyoto University 31
Kyoto University And iPS Academia Enter Into Licensing Agreement With iPierian 32
Kyoto University, Key Competitors 33
Kyoto University, Key Employees 34
Kyoto University, Other Locations 35
Kyoto University, Subsidiaries 35